Difference in the Vitreal Protein Profiles of Patients with Proliferative Diabetic Retinopathy with and without Intravitreal Conbercept Injection

Difference in the Vitreal Protein Profiles of Patients with Proliferative Diabetic Retinopathy with and without Intravitreal Conbercept Injection

Purpose. To examine the difference in the vitreal protein profiles of patients with proliferative diabetic retinopathy (PDR) with and without preoperative intravitreal conbercept (IVC) treatment. Methods. Liquid chromatography-tandem mass spectrometry- (LC-MS/MS-) based proteomic methods were used t...

Full description

Bibliographic Details
Main Authors:	Chen Zou, Minjie Zhao, Jingjing Yu, Dandan Zhu, Yunzhi Wang, Xinping She, Yanan Hu, Zhi Zheng
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2018/7397610

Similar Items

Intravitreal injection of Conbercept combined with PPV in the treatment of proliferative diabetic retinopathy
by: Zhou Ou, et al.
Published: (2021-06-01)

Effects of vitrectomy with preoperative intravitreal Conbercept for proliferative diabetic retinopathy
by: Huai-Sheng Zhou, et al.
Published: (2018-02-01)

Effect of intravitreal conbercept treatment before vitrectomy in proliferative diabetic retinopathy
by: Jian-Bo Mao, et al.
Published: (2018-07-01)

The influence of intravitreally applied triamcinolone acetonide on vitreal hemorrhage resorption and visual acuity in patients with proliferative diabetic retinopathy
by: Petrović Nenad, et al.
Published: (2018-01-01)

Clinical effect of 25G+ vitrectomy combined with intravitreal injection of Conbercept in the treatment of severe proliferative diabetic retinopathy
by: Yong-Mou Zhou, et al.
Published: (2017-12-01)

Systematic evaluation of the effectiveness and safety of intravitreal injection of Conbercept for diabetic retinopathy
by: Chun-Xing Li, et al.
Published: (2018-10-01)

Preoperative Intravitreal Conbercept Facilitates Vitrectomy in Proliferative Diabetic Retinopathy: Is Attention Required for the Fellow Eye?
by: Wei Xu, et al.
Published: (2019-01-01)

Intravitreal injection of Conbercept-assisted vitrectomy for the treatment of proliferative diabetic retinopathy and its effects on inflammatory factors and ANGPTL4 in the vitreous
by: Si-Hua Cheng, et al.
Published: (2019-12-01)

Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy
by: Jinglin Cui, et al.
Published: (2018-01-01)

A lower dose of intravitreal conbercept effectively treats retinopathy of prematurity
by: Yong Cheng, et al.
Published: (2018-07-01)

Vascular endothelial growth factor concentration in vitreous humor of patients with severe proliferative diabetic retinopathy after intravitreal injection of conbercept as an adjunctive therapy for vitrectomy
by: Bing Li, et al.
Published: (2020-03-01)

Effect of vitrectomy with intravitreal injection of triamcinolone acetonide in the treatment of proliferative diabetic retinopathy
by: Heng Li, et al.
Published: (2015-10-01)

Clinical study of Conbercept in patients with proliferative diabetic retinopathy undergoing vitrectomy
by: Shao-Hua Shi, et al.
Published: (2020-05-01)

Clinical effect of intravitreal injection of Ranibizumab for severe proliferative diabetic retinopathy
by: Yun-Cheng Ma, et al.
Published: (2016-01-01)

Efficacy of intravitreal injection of Conbercept in the treatment of diabetic macular edema
by: Chen Jiang, et al.
Published: (2018-02-01)

Clinical observation of intravitreal injection of Conbercept treating diabetic macularedema
by: Li Jiang, et al.
Published: (2017-06-01)

Intravitreal conbercept injection for neovascular age-related macular degeneration
by: Bing-Hui Wu, et al.
Published: (2019-02-01)

Influence of vitreal reflux on intraocular pressure after intravitreal application of bevacizumab
by: Đogatović Nebojša, et al.
Published: (2020-01-01)

Ghost cell glaucoma after intravitreous injection of ranibizumab in proliferative diabetic retinopathy
by: Jun Xu, et al.
Published: (2020-04-01)

Effect of intravitreal injection of Bevacizumab for vitreous hemorrhage in patients with proliferative diabetic retinopathy
by: Na Meng, et al.
Published: (2016-05-01)

Cytokine and Chemokine Profile Changes in Patients After Intravitreal Conbercept Injection for Diabetic Macular Edema
by: Wei Q, et al.
Published: (2019-12-01)

Increased vitreal levels of interleukin-10 in diabetic retinopathy: a Meta-analysis
by: Wei Tan, et al.
Published: (2020-09-01)

Comment on “Intravitreal conbercept injection for neovascular age-related macular degeneration”
by: Dan Călugăru, et al.
Published: (2020-02-01)

Intravitreal injection of Conbercept in the treatment of exudative age-related macular degeneration
by: Hong-Xia Niu, et al.
Published: (2018-09-01)

Effect of intravitreal injection of conbercept on neovascular age-related macular degeneration
by: Tao Li, et al.
Published: (2019-04-01)

Effect of intravitreal injection of Conbercept with laser photocoagulation on diabetic macular edema
by: Qiu-Xia Li, et al.
Published: (2018-06-01)

Intravitreal injection of conbercept combined with triamcinolone acetonide for diabetic macular edema
by: Jun Li<sup>*</sup>, et al.
Published: (2019-03-01)

A Randomized Controlled Trial of Conbercept Pretreatment before Vitrectomy in Proliferative Diabetic Retinopathy
by: Xiaochun Yang, et al.
Published: (2016-01-01)

Clinical observation of intravitreal injection of Conbercept treating exudative age-related macular degeneration
by: Wei Song, et al.
Published: (2016-07-01)

Evaluation of RNFL thickness and serum cytokine levels after retinal photocoagulation combined with intravitreous Conbercept injection treatment of diabetic retinopathy
by: Luo Na
Published: (2016-08-01)

Intravitreal injection of Conbercept combined with trabeculectomy and panretinal photocoagulation for the treatment of neovascular glaucoma
by: Zhe Yu, et al.
Published: (2018-05-01)

Intravitreal injection of Conbercept for macular edema due to branch retinal vein occlusion
by: Qi Cai, et al.
Published: (2018-05-01)

Effect and safety of PPV assisted by intravitreal injection of Conbercept in the treatment of PDR combined with vitreous hemorrhage
by: Chun-Shi Li, et al.
Published: (2021-09-01)

Efficacy comparison of Conbercept and Ranibizumab as pre-treatment for pars plana vitrectomy in proliferative diabetic retinopathy
by: Ni Yin, et al.
Published: (2017-07-01)

Intravitreal neurodegenerative and inflammatory mediators in proliferative diabetic retinopathy
by: Felipe Mallmann, et al.
Published: (2019-04-01)

Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy
by: Shaikh Saad
Published: (2008-01-01)

Panretinal photocoagulation versus intravitreal injection retreatment pain in high-risk proliferative diabetic retinopathy
by: Célia Regina Farias de Araújo Lucena, et al.
Published: (2013-02-01)

Effects of intravitreous injection on the expression of vascular endothelial growth inhibitor in vitreous of proliferative diabetic retinopathy
by: Rui Shi, et al.
Published: (2015-06-01)

Effect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy
by: Mehmet Demir, et al.
Published: (2013-07-01)

Retro-mode imaging of fibrovascular membrane in proliferative diabetic retinopathy after intravitreal bevacizumab injection
by: Fujikawa A, et al.
Published: (2011-06-01)